Asthma
3rd Edition
Published on 4. September 1998
Book
Hardback
464 pages
978-0-412-35900-2 (ISBN)
Description
The rising incidence of asthma, and the failure of modern treatment to reduce mortality makes it a subject of great concern. It is increasingly important to have a thorough understanding of asthma and to be able critically to evaluate new treatments. Our understanding of asthma has changed in the last ten years, so much that a revised and updated edition of this book on asthma became essential. This edition is the only reference on asthma that you need. It encompasses new developments, with particular emphasis on airway inflammation and reactivity, new drugs, new formulations of existing drugs, and better delivery systems. This book should not only improve understanding of asthma and give up-to-date knowledge, it also provides you with practical advice. This book should be of interest to respiratory physicians and allergists.
More details
Edition
3rd Revised edition
Language
English
Place of publication
London
United Kingdom
Publishing group
Taylor & Francis Ltd
Target group
College/higher education
Professional and scholarly
Edition type
Revised edition
Dimensions
Height: 165 mm
Width: 240 mm
Weight
1328 gr
ISBN-13
978-0-412-35900-2 (9780412359002)
Copyright in bibliographic data is held by Nielsen Book Services Limited or its licensors: all rights reserved.
Schweitzer Classification
Other editions
New editions
T.J.H. Clark | Tak Lee | Simon Godfrey
Asthma, 4Ed
Book
09/2000
4th Edition
Hodder Arnold
€135.19
Article is exhausted; no reprint
Persons
Content
Definition of asthma and its relationship to COPD, T.J. Clark; physiology, Neil Pride; exercises and hyperventilation induced asthma, S. Godfrey; airway responsiveness to pharmacological agents, P. O'Byrne; neural mechanisms in asthma, P.J. Barnes; mediators of bronchial activity, T. Lee; immunobiology of asthma, M.P. Carroll et al; pathology and cytology of asthma, A. Laitinen and A. Laitinen; morbidity, mortality, epidemiology, P. Burney; occupational and environmental factors, S. Burge; the beta agonist drug, A.E. Tattersfield and I.P. Hall; anti-cholinergic, N. Thomson; the methyl xanthines, M. Weinberger; corticosteroids, K.F. Chung and T.J.H. Clark; non-steroidal prophylactic agents, R. Pauwels; inhalation devices and techniques, S.P. Newman and S.W. Clarke; management of the adult with asthma, G.M. Cochrane; management of the child with asthma, S. Godfrey.